MX2007008349A - Nueva sintesis de una etapa de aminas disustituidas utiles. - Google Patents
Nueva sintesis de una etapa de aminas disustituidas utiles.Info
- Publication number
- MX2007008349A MX2007008349A MX2007008349A MX2007008349A MX2007008349A MX 2007008349 A MX2007008349 A MX 2007008349A MX 2007008349 A MX2007008349 A MX 2007008349A MX 2007008349 A MX2007008349 A MX 2007008349A MX 2007008349 A MX2007008349 A MX 2007008349A
- Authority
- MX
- Mexico
- Prior art keywords
- new
- step synthesis
- disubstituted amines
- useful
- useful disubstituted
- Prior art date
Links
- 150000001412 amines Chemical class 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- AMRJKAQTDDKMCE-UHFFFAOYSA-N dolastatin Chemical class CC(C)C(N(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(C(C)C)C(OC)CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(C=1SC=CN=1)CC1=CC=CC=C1 AMRJKAQTDDKMCE-UHFFFAOYSA-N 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229910003002 lithium salt Inorganic materials 0.000 abstract 1
- 159000000002 lithium salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/52—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
La presente invencion se relaciona con la manufactura de los compuestos de la formula (I), siendo estos compuestos de la formula (I) o sus sales de litio, intermediarios valiosos en la manufactura de analogos de Dolastatina, que son utiles en el tratamiento de cancer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05100180 | 2005-01-13 | ||
| PCT/EP2006/000046 WO2006074873A2 (en) | 2005-01-13 | 2006-01-05 | New one-step synthesis of useful disubstituted amines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007008349A true MX2007008349A (es) | 2007-07-25 |
Family
ID=36654131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007008349A MX2007008349A (es) | 2005-01-13 | 2006-01-05 | Nueva sintesis de una etapa de aminas disustituidas utiles. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060155110A1 (es) |
| EP (1) | EP1838660A2 (es) |
| JP (1) | JP2008526908A (es) |
| KR (1) | KR20070087025A (es) |
| CN (1) | CN101102993A (es) |
| AU (1) | AU2006205909A1 (es) |
| BR (1) | BRPI0605940A2 (es) |
| CA (1) | CA2592969A1 (es) |
| IL (1) | IL184354A0 (es) |
| MX (1) | MX2007008349A (es) |
| TW (1) | TW200720225A (es) |
| WO (1) | WO2006074873A2 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011100403A1 (en) | 2010-02-10 | 2011-08-18 | Immunogen, Inc | Cd20 antibodies and uses thereof |
| CN102816203B (zh) * | 2011-06-10 | 2014-09-03 | 上海医药工业研究院 | 一种取代喹啉类化合物及其制备方法、药物组合物和应用 |
| US10832917B2 (en) * | 2017-06-09 | 2020-11-10 | International Business Machines Corporation | Low oxygen cleaning for CMP equipment |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995009864A1 (en) * | 1993-10-01 | 1995-04-13 | Teikoku Hormone Mfg. Co., Ltd. | Novel peptide derivative |
| JP4116085B2 (ja) * | 1996-12-18 | 2008-07-09 | テバ・ファーマシューティカル・インダストリーズ・リミテッド | フェニルエチルアミン誘導体 |
| US6737409B2 (en) * | 2001-07-19 | 2004-05-18 | Hoffmann-La Roche Inc. | Dolastatin 10 derivatives |
-
2006
- 2006-01-05 WO PCT/EP2006/000046 patent/WO2006074873A2/en not_active Ceased
- 2006-01-05 CA CA002592969A patent/CA2592969A1/en not_active Abandoned
- 2006-01-05 EP EP06706166A patent/EP1838660A2/en not_active Withdrawn
- 2006-01-05 AU AU2006205909A patent/AU2006205909A1/en not_active Abandoned
- 2006-01-05 KR KR1020077015844A patent/KR20070087025A/ko not_active Ceased
- 2006-01-05 BR BRPI0605940-6A patent/BRPI0605940A2/pt not_active Application Discontinuation
- 2006-01-05 MX MX2007008349A patent/MX2007008349A/es not_active Application Discontinuation
- 2006-01-05 CN CNA2006800022339A patent/CN101102993A/zh active Pending
- 2006-01-05 JP JP2007550733A patent/JP2008526908A/ja active Pending
- 2006-01-10 TW TW095100912A patent/TW200720225A/zh unknown
- 2006-01-11 US US11/330,317 patent/US20060155110A1/en not_active Abandoned
-
2007
- 2007-07-02 IL IL184354A patent/IL184354A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006205909A1 (en) | 2006-07-20 |
| US20060155110A1 (en) | 2006-07-13 |
| IL184354A0 (en) | 2007-10-31 |
| CN101102993A (zh) | 2008-01-09 |
| JP2008526908A (ja) | 2008-07-24 |
| KR20070087025A (ko) | 2007-08-27 |
| CA2592969A1 (en) | 2006-07-20 |
| WO2006074873A2 (en) | 2006-07-20 |
| WO2006074873A3 (en) | 2006-11-02 |
| TW200720225A (en) | 2007-06-01 |
| EP1838660A2 (en) | 2007-10-03 |
| BRPI0605940A2 (pt) | 2009-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200716606A (en) | Chemical compounds | |
| TW200800963A (en) | Chemical compounds | |
| SI1853602T1 (sl) | Kemične spojine | |
| PL1853588T3 (pl) | Związki chemiczne | |
| PH12013500745A1 (en) | Azaadamantane derivatives and methods of use | |
| TW200722079A (en) | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein | |
| CY1119077T1 (el) | Παραγωγα πυραζολυλαμινοπυριδινης χρησιμα ως αναστολεις κινασων | |
| SE0303180D0 (sv) | Novel compounds | |
| SE0302232D0 (sv) | Novel Compounds | |
| CY1112467T1 (el) | Παραγωγα 1-θειο-d-γλυκιτολης | |
| CY1107956T1 (el) | Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον | |
| EA201101015A1 (ru) | Способ получения бивалирудина | |
| EA201170344A1 (ru) | Азаиндольные ингибиторы iap | |
| TW200720260A (en) | Prokineticin 1 receptor antagonists | |
| TW200716566A (en) | Prokineticin 2 receptor antagonists | |
| TW200640912A (en) | Novel processes for the preparation of a 2H-chromene | |
| TW200633977A (en) | Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives | |
| TW200716564A (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
| TW200738713A (en) | Diazepinoquinolines, synthesis thereof, and intermediates thereto | |
| DE602005011784D1 (de) | Pyrazoloä4,3-düpyrimidine | |
| TNSN06260A1 (en) | Process for the preparation of tryptase inhibitors | |
| MX2007008349A (es) | Nueva sintesis de una etapa de aminas disustituidas utiles. | |
| TW200635905A (en) | Processes for producing 4-aminoquinazolines | |
| IN2012DN03819A (es) | ||
| DE60306636D1 (de) | Wachstumhormonsekretionsförderer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |